CARDIOVASCULAR MEDICINE

Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure

T Mueller¹, A Gegenhuber², W Poelz³, M Haltmayer¹

¹ Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria
² Department of Internal Medicine, Konventhospital Barmherzige Brueder
³ Institute for Applied System Sciences and Statistics, University of Linz

Correspondence to:
Correspondence to:
Dr Meinhard Haltmayer
Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Seilerstaette 2, A-4021 Linz, Austria; meinhard.haltmayer{at}bblinz.at

Objective: To compare head to head the diagnostic accuracy of B type natriuretic peptide (BNP) and the amino terminal fragment of its precursor hormone (NT-proBNP) for congestive heart failure (CHF) in an emergency setting.

Methods: 251 consecutive patients presenting to the emergency department with dyspnoea as a chief complaint were prospectively studied. Patients with acute coronary syndromes were excluded. The diagnosis of CHF was based on the Framingham score for CHF plus echocardiographic evidence of systolic or diastolic dysfunction. Blood concentrations of BNP and NT-proBNP were measured by two commercially available assays (Abbott and Roche methods). The diagnostic accuracies of BNP and NT-proBNP were assessed by receiver operating characteristic curve analysis.

Results: Areas under the curve for BNP and NT-proBNP in patients with dyspnoea caused by CHF (n = 137) and in patients with dyspnoea attributable to other reasons (n = 114) did not differ significantly (area under the curve 0.916 v 0.903, p = 0.277, statistical power 94%). Cut off concentrations with the highest diagnostic accuracy were 295 ng/l for BNP (sensitivity 80%, specificity 86%, diagnostic accuracy 83%) and 825 ng/l for NT-proBNP (sensitivity 87%, specificity 81%, diagnostic accuracy 84%). Evaluation of discordant false classifications at these cut off concentrations showed no advantage for either BNP nor NT-proBNP in the biochemical diagnosis of CHF (17 misclassifications by BNP and 14 by NT-proBNP, p = 0.720). In the population studied, age, sex, and renal function had no impact on the diagnostic utility of both tests when compared by logistic regression models.

Conclusions: BNP and NT-proBNP may be equally useful as an aid in the diagnosis of CHF in short of breath patients presenting to the emergency department.

Abbreviations: AUC, area under the curve; BNP, B type natriuretic peptide; BNP study, breathing not properly study; CHF, congestive heart failure; CV, coefficient of variance; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; NCCLS, National Committee for Clinical Laboratory Standards; NT-proBNP, amino terminal fragment of proBNP; ROC, receiver operating characteristic; STARD, standards for reporting of diagnostic accuracy

Keywords: diagnosis; echocardiography; heart failure; natriuretic peptides

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Dieplinger, B, Gegenhuber, A, Haltmayer, M, Mueller, T (2009). Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath. Heart 95: 1508-1513 [Abstract] [Full Text]  
• Mueller, T., Dieplinger, B., Poelz, W., Endler, G., Wagner, O. F., Haltmayer, M. (2009). Amino-Terminal Pro-B-Type Natriuretic Peptide as Predictor of Mortality in Patients with Symptomatic Peripheral Arterial Disease: 5-Year Follow-Up Data from the Linz Peripheral Arterial Disease Study. Clin. Chem. 55: 68-77 [Abstract] [Full Text]  
• Laskowitz, D. T., Kasner, S. E., Saver, J., Remmel, K. S., Jauch, E. C., BRAIN Study Group, (2009). Clinical Usefulness of a Biomarker-Based Diagnostic Test for Acute Stroke: The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) Study. Stroke 40: 77-85 [Abstract] [Full Text]  
• Ray, P., Delerme, S., Jourdain, P., Chenevier-Gobeaux, C. (2008). Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department. QJM 101: 831-843 [Abstract] [Full Text]  
• Rehman, S. U., Mueller, T., Januzzi, J. L. Jr (2008). Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure. J Am Coll Cardiol 52: 1458-1465 [Abstract] [Full Text]  
• deFilippi, C. R., Seliger, S. L., Maynard, S., Christenson, R. H. (2007). Impact of Renal Disease on Natriuretic Peptide Testing for Diagnosing Decompensated Heart Failure and Predicting Mortality. Clin. Chem. 53: 1511-1519 [Abstract] [Full Text]  
• Emdin, M., Passino, C., Prontera, C., Fontana, M., Poletti, R., Gabutti, A., Mammini, C., Giannoni, A., Zyw, L., Zucchelli, G., Clerico, A. (2007). Comparison of Brain Natriuretic Peptide (BNP) and Amino-Terminal ProBNP for Early Diagnosis of Heart Failure. Clin. Chem. 53: 1289-1297 [Abstract] [Full Text]  
• El-Khuffash, A., Molloy, E. J (2007). Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?. Arch. Dis. Child. Fetal Neonatal Ed. 92: F320-F324 [Abstract] [Full Text]  
• Lang, C. C, Mancini, D. M (2007). Non-cardiac comorbidities in chronic heart failure. Heart 93: 665-671 [Abstract] [Full Text]  
• Kremastinos, D. Th., Tsiapras, D. P., Kostopoulou, A. G., Hamodraka, E. S., Chaidaroglou, A. S., Kapsali, E. D. (2007). NT-proBNP levels and diastolic dysfunction in {beta}-Thalassaemia major patients. Eur J Heart Fail 9: 531-536 [Abstract] [Full Text]  
• Corteville, D. C. M., Bibbins-Domingo, K., Wu, A. H. B., Ali, S., Schiller, N. B., Whooley, M. A. (2007). N-Terminal Pro-B-Type Natriuretic Peptide as a Diagnostic Test for Ventricular Dysfunction in Patients With Coronary Disease: Data From the Heart and Soul Study. Arch Intern Med 167: 483-489 [Abstract] [Full Text]  
• Date, T, Yamane, T, Inada, K, Matsuo, S, Miyanaga, S, Sugimoto, K, Shibayama, K, Taniguchi, I, Mochizuki, S (2006). Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation. Heart 92: 1623-1627 [Abstract] [Full Text]  
• Jelic, S., Le Jemtel, T. H. (2006). Diagnostic Usefulness of B-Type Natriuretic Peptide and Functional Consequences of Muscle Alterations in COPD and Chronic Heart Failure.. Chest 130: 1220-1230 [Abstract] [Full Text]  
• Kolditz, M., Halank, M., Schiemanck, C. S., Schmeisser, A., Hoffken, G. (2006). High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 28: 144-150 [Abstract] [Full Text]  
• Weber, M., Hamm, C. (2006). Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine.. Heart 92: 843-849 [Full Text]  
• Gegenhuber, A., Struck, J., Poelz, W., Pacher, R., Morgenthaler, N. G., Bergmann, A., Haltmayer, M., Mueller, T. (2006). Midregional Pro-A-Type Natriuretic Peptide Measurements for Diagnosis of Acute Destabilized Heart Failure in Short-of-Breath Patients: Comparison with B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP. Clin. Chem. 52: 827-831 [Abstract] [Full Text]  
• Mueller, T., Gegenhuber, A., Dieplinger, B., Poelz, W., Haltmayer, M. (2005). Capability of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP as Indicators of Cardiac Structural Disease in Asymptomatic Patients with Systemic Arterial Hypertension. Clin. Chem. 51: 2245-2251 [Abstract] [Full Text]  
• Wang, C. S., FitzGerald, J. M., Schulzer, M., Mak, E., Ayas, N. T. (2005). Does This Dyspneic Patient in the Emergency Department Have Congestive Heart Failure?. JAMA 294: 1944-1956 [Abstract] [Full Text]  
• Doust, J. (2005). BNP and amino terminal proBNP assays did not differ for detecting congestive heart failure in the emergency department. Evid. Based Med. 10: 148-148 [Full Text]  
• Gegenhuber, A., Mueller, T., Dieplinger, B., Lenz, K., Poelz, W., Haltmayers, M. (2005). Plasma B-Type Natriuretic Peptide in Patients With Pleural Effusions: Preliminary Observations. Chest 128: 1003-1009 [Abstract] [Full Text]